Sitagliptin + Metformin tablets
Form: Tablets
Strength: 50/500 mg, 50/850 mg, 50/1000 mg
Reference Brands: Janumet (US & EU)
Category: Diabetes
Sitagliptin + Metformin tablets are FDA-approved in the USA and EMA-authorized in the EU for managing type 2 diabetes. These fixed-dose combination tablets comply with GMP standards and serve as adjuncts to diet and exercise. Marketed under brands like Janumet®, they require regulatory labeling for risks like lactic acidosis and renal impairment. Pharmacovigilance is mandatory in both regions. Manufacturers must adhere to 21 CFR (USA) and EMA Modules 1–5 (EU). For regulatory support, sourcing, or B2B pharma solutions, visit PharmaTradz.com — your global partner in compliant pharmaceutical trade.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Premixed Insulins (70/30, 50/50) Injectable
Strength: U-100
Form: Vials, pens
Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)
View Details Get Enquiry
Insulin Lispro (Humalog) injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)
View Details Get Enquiry
Insulin Aspart (Novolog) injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Novolog, Fiasp(US &EU)
View Details Get Enquiry
Insulin Glargine (Lantus) injectable
Strength: U-100, U-300
Form: Vials/pens
Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)
View Details Get Enquiry